Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non–small cell lung cancer
Objective Intratumoral vessel invasion of non–small cell lung cancer is a readily available tumor-related factor that provides direct evidence of microscopic tumor invasion. We assessed the prognostic influence of intratumoral vessel invasion and its ability to provide a differential prediction of p...
Gespeichert in:
Veröffentlicht in: | The Journal of thoracic and cardiovascular surgery 2009-02, Vol.137 (2), p.429-434 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 434 |
---|---|
container_issue | 2 |
container_start_page | 429 |
container_title | The Journal of thoracic and cardiovascular surgery |
container_volume | 137 |
creator | Miyoshi, Kentaroh, MD Moriyama, Shigeharu, MD Kunitomo, Tadayoshi, MD Nawa, Sugato, MD |
description | Objective Intratumoral vessel invasion of non–small cell lung cancer is a readily available tumor-related factor that provides direct evidence of microscopic tumor invasion. We assessed the prognostic influence of intratumoral vessel invasion and its ability to provide a differential prediction of prognosis for completely resected pathologic stage I non–small cell lung cancer. Methods We analyzed 258 patients with non–small cell lung cancer who underwent complete resection between January of 1996 and December of 2005 and were diagnosed with pathologic stage I disease. In addition to the conventional staging factors, intratumoral vessel invasion in the primary lesion was histologically evaluated by both hematoxylin-eosin and elastic staining. We examined the significance of intratumoral vessel invasion in prognosis and compared the outcomes between patients with and without this factor with stage IA and IB disease, respectively. Results Intratumoral vessel invasion was found in 124 patients (48%). Five-year survival of patients with or without intratumoral vessel invasion was 74% and 93%, respectively. On multivariate analysis, intratumoral vessel invasion and pleural invasion were shown to be independent prognostic factors. Subgroup analyses suggested that patients with pathologic-stage IA with intratumoral vessel invasion and patients with pathologic-stage IB with both intratumoral vessel and pleural invasion had significantly worse prognosis than patients with the same pathologic stage without these factors. Conclusion The current study indicated that intratumoral vessel invasion and pleural invasion are independent prognostic factors. Intratumoral vessel invasion status can complement the size-dependent TNM staging system in pathologic stage I non–small cell lung cancer. |
doi_str_mv | 10.1016/j.jtcvs.2008.07.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66872971</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002252230801177X</els_id><sourcerecordid>66872971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c585t-b2911bc2c2461ab1ffb0fa1c8152afcfe714b6576361ed31ed2444e63cddf4f23</originalsourceid><addsrcrecordid>eNqFks2KFDEUhQtRnHb0CQTJRl11m5uqSqoWCjL4MzCgoMLsQip10502VelJUq298x18Q5_E1HSj4MZFfgjfObn3JEXxGOgKKPAX29U26X1cMUqbFRUrSsWdYgG0FUve1Nd3iwWljC1rxsqz4kGMW5oJCu394gxaaGrg9aL4_jH49ehjsprYYad0It4QO6ag0jT4oBzZY4zo8tleRevHvCHaDzuHCd2BBIyoE_Zkp9LGO7_ORjGpNZJLMvrx14-fcVDOEY15ctO4JlqNGsPD4p5RLuKj03pefHn75vPF--XVh3eXF6-vlrpu6rTsWAvQaaZZxUF1YExHjQLdQM2U0QYFVB2vBS85YF_mwaqqQl7qvjeVYeV58ezouwv-ZsKY5GDjXIwa0U9Rct4I1grIYHkEdfAxBjRyF-ygwkEClXPgcitvA5dz4JIKmePMqicn-6kbsP-rOSWcgacnQEWtnAm5exv_cAxyI7zlmXt-5DZ2vflmA8rb3LItzNdGKIVksmJtJl8eScyx7S0GGbXFnGmfVTrJ3tv_lPzqH712drS5uK94wLj1Uxjzi0iQkUkqP82_aP5EtKEAQlyXvwHvgMZL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66872971</pqid></control><display><type>article</type><title>Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non–small cell lung cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Miyoshi, Kentaroh, MD ; Moriyama, Shigeharu, MD ; Kunitomo, Tadayoshi, MD ; Nawa, Sugato, MD</creator><creatorcontrib>Miyoshi, Kentaroh, MD ; Moriyama, Shigeharu, MD ; Kunitomo, Tadayoshi, MD ; Nawa, Sugato, MD</creatorcontrib><description>Objective Intratumoral vessel invasion of non–small cell lung cancer is a readily available tumor-related factor that provides direct evidence of microscopic tumor invasion. We assessed the prognostic influence of intratumoral vessel invasion and its ability to provide a differential prediction of prognosis for completely resected pathologic stage I non–small cell lung cancer. Methods We analyzed 258 patients with non–small cell lung cancer who underwent complete resection between January of 1996 and December of 2005 and were diagnosed with pathologic stage I disease. In addition to the conventional staging factors, intratumoral vessel invasion in the primary lesion was histologically evaluated by both hematoxylin-eosin and elastic staining. We examined the significance of intratumoral vessel invasion in prognosis and compared the outcomes between patients with and without this factor with stage IA and IB disease, respectively. Results Intratumoral vessel invasion was found in 124 patients (48%). Five-year survival of patients with or without intratumoral vessel invasion was 74% and 93%, respectively. On multivariate analysis, intratumoral vessel invasion and pleural invasion were shown to be independent prognostic factors. Subgroup analyses suggested that patients with pathologic-stage IA with intratumoral vessel invasion and patients with pathologic-stage IB with both intratumoral vessel and pleural invasion had significantly worse prognosis than patients with the same pathologic stage without these factors. Conclusion The current study indicated that intratumoral vessel invasion and pleural invasion are independent prognostic factors. Intratumoral vessel invasion status can complement the size-dependent TNM staging system in pathologic stage I non–small cell lung cancer.</description><identifier>ISSN: 0022-5223</identifier><identifier>EISSN: 1097-685X</identifier><identifier>DOI: 10.1016/j.jtcvs.2008.07.007</identifier><identifier>PMID: 19185165</identifier><identifier>CODEN: JTCSAQ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adenocarcinoma - pathology ; Adenocarcinoma - surgery ; Adult ; Aged ; Aged, 80 and over ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - surgery ; Cardiology. Vascular system ; Cardiothoracic Surgery ; Female ; Humans ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Male ; Medical sciences ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Staging ; Pleura - pathology ; Pneumology ; Prognosis ; Retrospective Studies ; Survival Analysis ; Tumors of the respiratory system and mediastinum</subject><ispartof>The Journal of thoracic and cardiovascular surgery, 2009-02, Vol.137 (2), p.429-434</ispartof><rights>The American Association for Thoracic Surgery</rights><rights>2009 The American Association for Thoracic Surgery</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c585t-b2911bc2c2461ab1ffb0fa1c8152afcfe714b6576361ed31ed2444e63cddf4f23</citedby><cites>FETCH-LOGICAL-c585t-b2911bc2c2461ab1ffb0fa1c8152afcfe714b6576361ed31ed2444e63cddf4f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S002252230801177X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21152696$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19185165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miyoshi, Kentaroh, MD</creatorcontrib><creatorcontrib>Moriyama, Shigeharu, MD</creatorcontrib><creatorcontrib>Kunitomo, Tadayoshi, MD</creatorcontrib><creatorcontrib>Nawa, Sugato, MD</creatorcontrib><title>Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non–small cell lung cancer</title><title>The Journal of thoracic and cardiovascular surgery</title><addtitle>J Thorac Cardiovasc Surg</addtitle><description>Objective Intratumoral vessel invasion of non–small cell lung cancer is a readily available tumor-related factor that provides direct evidence of microscopic tumor invasion. We assessed the prognostic influence of intratumoral vessel invasion and its ability to provide a differential prediction of prognosis for completely resected pathologic stage I non–small cell lung cancer. Methods We analyzed 258 patients with non–small cell lung cancer who underwent complete resection between January of 1996 and December of 2005 and were diagnosed with pathologic stage I disease. In addition to the conventional staging factors, intratumoral vessel invasion in the primary lesion was histologically evaluated by both hematoxylin-eosin and elastic staining. We examined the significance of intratumoral vessel invasion in prognosis and compared the outcomes between patients with and without this factor with stage IA and IB disease, respectively. Results Intratumoral vessel invasion was found in 124 patients (48%). Five-year survival of patients with or without intratumoral vessel invasion was 74% and 93%, respectively. On multivariate analysis, intratumoral vessel invasion and pleural invasion were shown to be independent prognostic factors. Subgroup analyses suggested that patients with pathologic-stage IA with intratumoral vessel invasion and patients with pathologic-stage IB with both intratumoral vessel and pleural invasion had significantly worse prognosis than patients with the same pathologic stage without these factors. Conclusion The current study indicated that intratumoral vessel invasion and pleural invasion are independent prognostic factors. Intratumoral vessel invasion status can complement the size-dependent TNM staging system in pathologic stage I non–small cell lung cancer.</description><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Cardiology. Vascular system</subject><subject>Cardiothoracic Surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Staging</subject><subject>Pleura - pathology</subject><subject>Pneumology</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0022-5223</issn><issn>1097-685X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks2KFDEUhQtRnHb0CQTJRl11m5uqSqoWCjL4MzCgoMLsQip10502VelJUq298x18Q5_E1HSj4MZFfgjfObn3JEXxGOgKKPAX29U26X1cMUqbFRUrSsWdYgG0FUve1Nd3iwWljC1rxsqz4kGMW5oJCu394gxaaGrg9aL4_jH49ehjsprYYad0It4QO6ag0jT4oBzZY4zo8tleRevHvCHaDzuHCd2BBIyoE_Zkp9LGO7_ORjGpNZJLMvrx14-fcVDOEY15ctO4JlqNGsPD4p5RLuKj03pefHn75vPF--XVh3eXF6-vlrpu6rTsWAvQaaZZxUF1YExHjQLdQM2U0QYFVB2vBS85YF_mwaqqQl7qvjeVYeV58ezouwv-ZsKY5GDjXIwa0U9Rct4I1grIYHkEdfAxBjRyF-ygwkEClXPgcitvA5dz4JIKmePMqicn-6kbsP-rOSWcgacnQEWtnAm5exv_cAxyI7zlmXt-5DZ2vflmA8rb3LItzNdGKIVksmJtJl8eScyx7S0GGbXFnGmfVTrJ3tv_lPzqH712drS5uK94wLj1Uxjzi0iQkUkqP82_aP5EtKEAQlyXvwHvgMZL</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Miyoshi, Kentaroh, MD</creator><creator>Moriyama, Shigeharu, MD</creator><creator>Kunitomo, Tadayoshi, MD</creator><creator>Nawa, Sugato, MD</creator><general>Mosby, Inc</general><general>AATS/WTSA</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090201</creationdate><title>Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non–small cell lung cancer</title><author>Miyoshi, Kentaroh, MD ; Moriyama, Shigeharu, MD ; Kunitomo, Tadayoshi, MD ; Nawa, Sugato, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c585t-b2911bc2c2461ab1ffb0fa1c8152afcfe714b6576361ed31ed2444e63cddf4f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Cardiology. Vascular system</topic><topic>Cardiothoracic Surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Staging</topic><topic>Pleura - pathology</topic><topic>Pneumology</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miyoshi, Kentaroh, MD</creatorcontrib><creatorcontrib>Moriyama, Shigeharu, MD</creatorcontrib><creatorcontrib>Kunitomo, Tadayoshi, MD</creatorcontrib><creatorcontrib>Nawa, Sugato, MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miyoshi, Kentaroh, MD</au><au>Moriyama, Shigeharu, MD</au><au>Kunitomo, Tadayoshi, MD</au><au>Nawa, Sugato, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non–small cell lung cancer</atitle><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle><addtitle>J Thorac Cardiovasc Surg</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>137</volume><issue>2</issue><spage>429</spage><epage>434</epage><pages>429-434</pages><issn>0022-5223</issn><eissn>1097-685X</eissn><coden>JTCSAQ</coden><abstract>Objective Intratumoral vessel invasion of non–small cell lung cancer is a readily available tumor-related factor that provides direct evidence of microscopic tumor invasion. We assessed the prognostic influence of intratumoral vessel invasion and its ability to provide a differential prediction of prognosis for completely resected pathologic stage I non–small cell lung cancer. Methods We analyzed 258 patients with non–small cell lung cancer who underwent complete resection between January of 1996 and December of 2005 and were diagnosed with pathologic stage I disease. In addition to the conventional staging factors, intratumoral vessel invasion in the primary lesion was histologically evaluated by both hematoxylin-eosin and elastic staining. We examined the significance of intratumoral vessel invasion in prognosis and compared the outcomes between patients with and without this factor with stage IA and IB disease, respectively. Results Intratumoral vessel invasion was found in 124 patients (48%). Five-year survival of patients with or without intratumoral vessel invasion was 74% and 93%, respectively. On multivariate analysis, intratumoral vessel invasion and pleural invasion were shown to be independent prognostic factors. Subgroup analyses suggested that patients with pathologic-stage IA with intratumoral vessel invasion and patients with pathologic-stage IB with both intratumoral vessel and pleural invasion had significantly worse prognosis than patients with the same pathologic stage without these factors. Conclusion The current study indicated that intratumoral vessel invasion and pleural invasion are independent prognostic factors. Intratumoral vessel invasion status can complement the size-dependent TNM staging system in pathologic stage I non–small cell lung cancer.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>19185165</pmid><doi>10.1016/j.jtcvs.2008.07.007</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-5223 |
ispartof | The Journal of thoracic and cardiovascular surgery, 2009-02, Vol.137 (2), p.429-434 |
issn | 0022-5223 1097-685X |
language | eng |
recordid | cdi_proquest_miscellaneous_66872971 |
source | MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals |
subjects | Adenocarcinoma - pathology Adenocarcinoma - surgery Adult Aged Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - surgery Cardiology. Vascular system Cardiothoracic Surgery Female Humans Lung Neoplasms - pathology Lung Neoplasms - surgery Male Medical sciences Middle Aged Neoplasm Invasiveness Neoplasm Staging Pleura - pathology Pneumology Prognosis Retrospective Studies Survival Analysis Tumors of the respiratory system and mediastinum |
title | Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non–small cell lung cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A50%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20impact%20of%20intratumoral%20vessel%20invasion%20in%20completely%20resected%20pathologic%20stage%20I%20non%E2%80%93small%20cell%20lung%20cancer&rft.jtitle=The%20Journal%20of%20thoracic%20and%20cardiovascular%20surgery&rft.au=Miyoshi,%20Kentaroh,%20MD&rft.date=2009-02-01&rft.volume=137&rft.issue=2&rft.spage=429&rft.epage=434&rft.pages=429-434&rft.issn=0022-5223&rft.eissn=1097-685X&rft.coden=JTCSAQ&rft_id=info:doi/10.1016/j.jtcvs.2008.07.007&rft_dat=%3Cproquest_cross%3E66872971%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66872971&rft_id=info:pmid/19185165&rft_els_id=S002252230801177X&rfr_iscdi=true |